www.neurologiepropraxi.cz / Neurol. praxi. 2023;24(4):268-273 / NEUROLOGIE PRO PRAXI 273 PŘEHLEDOVÉ ČLÁNKY Epilepsie po cévní mozkové příhodě 31. Jung S, Schindler K, Findling O, et al. Adverse effect of early epileptic seizures in patients receiving endovascular therapy for acute stroke. Stroke. 2012;43(6):1584-1590. Available from: https:// doi.org/10.1161/STROKEAHA.111.645358. 32. Katsiki N, Mikhailidis DP, Nair Dr. The effects of antiepileptic drugs on vascular risk factors: a narrative review. Seizure. 2014;23(9):677-684. Available from: https://doi.org/10.1016/j. seizure.2014. 05. 011. 33. Kutlu G, Gomceli YB, Yasemin U, et al. Levetiracetam monotherapy for late poststroke seizures in the elderly’, Epilepsy & Behavior. 2008;13(3):542-544. Available from: https:// doi.org/10.1016/j.yebeh.2008. 04. 025. 34. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57(2):200-206. Available from: https://doi. org/10.1212/wnl.57. 2. 200. 35. Lahti AM, Saloheimo P, Huhtakangos J, et al. Poststroke epilepsy in long‑term survivors of primary intracerebral hemorrhage. Neurology. 2017;88(23):2169-2175. Available from: https:// doi.org/10.1212/WNL.0000000000004009. 36. Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long‑term outcomes after withdrawal of antiepileptic drugs in seizure‑free patients: a systematic review and individual participant data meta ‑analysis. The Lancet. Neurology. 2017;16(7):523531. Available from: https://doi.org/10.1016/S1474-4422(17)30114-X. 37. Mauritz M, Hirsch JL, Camfield P, et al. Acute symptomatic seizures: an educational, evidence‑based review. Epileptic Disor‑ ders. 2022;24(1):26-49. Available from: https://doi.org/10.1684/ epd.2021.1376. 38. Mecarelli O. Clinical Electroencephalography. Springer. 2019. 39. Okuda S, Takano S, Ueno M, et al. Clinical features of late ‑onset poststroke seizures’, Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2012;21(7):583-586. Available from: https://doi.org/10.1016/j. jstrokecerebrovasdis.2011. 01. 006. 40. Scoppettuolo P, Gaspard N, Depondt C, et al. Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG study’, Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology. 2019;130(12):2282-2286. Available from: https://doi.org/10.1016/j. clinph.2019. 09. 005. 41. Serafini A, Gigli GL, Gregoraci G, et al. Are Early Seizures Predictive of Epilepsy after a Stroke? Results of a Population‑Based Study. Neuroepidemiology. 2015;45(1):50-58. Available from: https://doi.org/10.1159/000382078. 42. Sheth KN, Martini SR, Moomaw CHJ, et al. Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study. Stroke. 2015;46(12):3532-3535. Available from: https://doi.org/10.1161/STROKEAHA.115.010875. 43. So EL, Annegers JF, Hauser WA, et al. Population‑based study of seizure disorders after cerebral infarction. Neurolo‑ gy. 1996;46(2):350-355. Available from: https://doi.org/10.1212/ wnl.46. 2. 350. 44. Talaat FM, Kamel T, Rabah AM, et al. Epilepsy and antiepileptic drugs: risk factors for atherosclerosis’, The International Journal of Neuroscience. 2015;125(7):507-511. Available from: https:// doi.org/10.3109/00207454.2014.949704. 45. Tanaka T, Ihara M. Post‑stroke epilepsy. Neurochemistry In‑ ternational. 2017;107_219-228. Available from: https://doi.org/10.1016/j.neuint.2017. 02. 002. 46. Trinka E, Brigo F. Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward. Current Opini‑ on in Neurology. 2014;27(2):227-235. Available from: https://doi. org/10.1097/WCO.0000000000000067. 47. Verrotti A, Manco R, Agostinelli S, et al. The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia. 2010;51(2):268-273. Available from: https://doi. org/10.1111/j.1528-1167.2009.02206.x. 48. Vitturi BK, Gagliardi RJ. The influence of statins on the risk of post‑stroke epilepsy’, Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2020;41(7):1851-1857. Available from: https://doi.org/10.1007/s10072-020-04298-5. 49. Wagner F, et al. Post‑stroke epilepsy: does stroke volume matter?. 2011:46-46. 50. Wang JZ, Manav VV, Saposnik G, et al. Incidence and management of seizures after ischemic stroke: Systematic review and meta‑analysis. Neurology. 2017;89(12):1220-1228. Available from: https://doi.org/10.1212/WNL.0000000000004407. 51. Witsch J, Frey HP, Schmidt JM, et al. Electroencephalographic Periodic Discharges and Frequency‑Dependent Brain Tissue Hypoxia in Acute Brain Injury. JAMA Neurology. 2017;74(3):301-309. Available from: https://doi.org/10.1001/jamaneurol.2016.5325. 52. Yiş U, Doğan M. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Bra‑ in & Development. 2012;34(3):185-188. Available from: https:// doi.org/10.1016/j.braindev.2011. 05. 009. 53. Zelano J, Redfors P, Asberg S, et al. Association between poststroke epilepsy and death: A nationwide cohort study. Eu‑ ropean Stroke Journal. 2016;1(4):272-278. Available from: https:// doi.org/10.1177/2396987316669000. 54. Zelano J, Holtkamp M, Agarwal N, et al. How to diagnose and treat post‑stroke seizures and epilepsy’, Epileptic Disorders: International Epilepsy Journal with Videotape. 2010;22(3):252263. Available from: https://doi.org/10.1684/epd.2020.1159. 55. Zeng K, Wang X, Xi Z, et al. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Clinical Neurology and Neurosur‑ gery. 2010;112(4):291-295. Available at: https://doi.org/10.1016/j. clineuro.2009. 12. 014. KNIHY EDUKAČNÍ MATERIÁLY BROŽURY ČASOPISY SUPPLEMENTA REPRINTY SEMINÁŘE AKCE NA KLÍČ KONGRESY E SHOP, ARCHIV ČLÁNKŮ, ON LINE VZDĚLÁVÁNÍ ON LINE Komunikujeme s lékaři všemi směry
RkJQdWJsaXNoZXIy NDA4Mjc=